Fri Mar 6 15:25:25 SGT 2015  
SINGAPORE
HAIR™
    Hair loss, Singapore (SG)

Hair loss, Singapore (SG)

Summary

Hair loss, Singapore (SG) @singaporehair_com: Hair loss treatment clinic, Singapore

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hair loss, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Is seborrhoeic dermatitis associated with a diffuse, low‐grade folliculitis and progressive cicatricial alopecia?
Thu, 05 Mar 2015 00:00:00 +0100 | Australasian Journal of Dermatology
This study seeks to demonstrate a unique relationship between a clinically identifiable chronic scalp dermatitis‐folliculitis with the characteristic histological features of low‐grade inflammatory fibrosing alopecia, resulting in a distinctive progressive cicatricial alopecia which we believe is prevalent and hitherto unrecognised, and befits the description of seborrhoeic folliculitis. The clinical, epidemiological and histopathological features of seborrhoeic folliculitis are demonstrated to establish its unique status among the disorders of adult diffuse cicatricial alopecia. (Source: Australasian Journal of Dermatology)

Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015...
Wed, 04 Mar 2015 00:55:10 +0100 | PRWeb: Medical Pharmaceuticals
RnRMarketResearch.com adds “Alopecia – Pipeline Review, H1 2015” report to its store. The report provides an overview of the alopecia therapeutic pipeline.(PRWeb March 03, 2015)Read the full story at http://www.prweb.com/releases/alopecia-pipeline-review/h1-2015-market-report/prweb12557105.htm (Source: PRWeb: Medical Pharmaceuticals)

Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study
Tue, 03 Mar 2015 19:40:27 +0100 | Dermatology
Conclusion: Bimatoprost solution represents a therapeutic option for scalp AA.Dermatology (Source: Dermatology)

Life After Ebola: Nurse Has Nightmares, Aches, Hair Loss
Tue, 03 Mar 2015 00:31:58 +0100 | ABC News: Health
Dallas nurse Nina Pham, 26, was the first person to catch Ebola on U.S. soil. (Source: ABC News: Health)

A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men
Tue, 03 Mar 2015 00:04:28 +0100 | Skin Pharmacology and Physiology
Conclusions: 5% MTF twice a day promotes hair density and width in both frontotemporal and vertex regions in men with moderate stages of AGA.Skin Pharmacol Physiol 2015;28:236-244 (Source: Skin Pharmacology and Physiology)

Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis
Tue, 03 Mar 2015 00:00:00 +0100 | Indian Journal of Dermatology
Kemal Ozyurt, Asli Subasioglu, Perihan Ozturk, Rahime Inci, Fuat Ozkan, Elena Bueno, Javier Cañueto, Rogelio González SarmientoIndian Journal of Dermatology 2015 60(2):216-216Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an inherited X-linked dominant variant of chondrodysplasia punctata which primarily affects the skin, bones, and eyes. CDPX2 patients display skin defects, including ichthyotic lesions, follicular atrophoderma, cicatricial alopecia, and less frequently ichthyosiform erythroderma, cataracts, and skeletal abnormalities consisting of short stature, asymmetric shortening of the limbs, epiphyseal stippling, and craniofacial defects. CDPX2 results from mutations in emopamil binding protein (EBP) gene. The aim of our study is to identify EBP ...

Chemotherapy and hair loss: What to expect during treatment
Tue, 03 Mar 2015 00:00:00 +0100 | MayoClinic.com Full Feed
(Source: MayoClinic.com Full Feed)

Pediatric Scalp Burns: Hair Today, Gone Tomorrow?
Sat, 28 Feb 2015 18:01:28 +0100 | Journal of Burn Care and Research
Scalp burns in the pediatric population appear relatively uncommon, with most reported cases occurring in adults secondary to electrical burns. We reviewed our experience with the management of these injuries in children. A retrospective review was conducted at our institution from March 2004 to July 2011. Scalp burns were defined as any burn crossing over the hairline into the scalp region. During the 7-year 4-month study, there were 107 scalp burns, representing 1.8% of the 6074 burns treated at our institution during that time. The cause was scald in 97, contact in 4, flame in 3, friction in 2, and chemical in 1. The majority (n = 93, 87%) appeared superficial to mid-dermal, with an average time to complete healing of 10.3 days. The remaining 14 cases (13%) were mid-dermal to full thick...

Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis.
Sat, 28 Feb 2015 17:48:24 +0100 | Cancer Control
Authors: Shin H, Jo SJ, Kim do H, Kwon O, Myung SK

Combination Therapy Helpful in Refractory AlopeciaCombination Therapy Helpful in Refractory Alopecia
Fri, 27 Feb 2015 21:36:53 +0100 | Medscape Dermatology Headlines
Combination therapy with diphenylcyclopropenone (DPCP) and anthralin is more effective than DPCP alone in patients with chronic extensive alopecia areata (AA), according to Turkish researchers. Reuters Health Information (Source: Medscape Dermatology Headlines)